SMAD7 and chronic kidney disease: Most importantly, the discovery that deletion of Smad7 increases renal fibrogenesis in diabetic nephropathy, obstructive nephropathy, and hypertensive nephropathy further defines the functional role of Smad7, suggesting Smad7 as a therapeutic agent for the treatment of CKD [26].